Craig-Hallum maintained a Buy rating on Amprius Technologies, Inc. (AMPX) on March 06, 2026, while raising the price target to $21. This AMPX analyst rating signals continued analyst confidence despite near-term stock weakness. The action comes after Amprius delivered Q4 2025 results and set a 2026 revenue target of $125,000,000, factors Craig-Hallum cited when keeping its Buy stance. Investors should read this change as a vote of confidence in growth potential, not a guarantee of short-term gains.
AMPX analyst rating: Craig-Hallum maintains Buy and raises PT to $21
Craig-Hallum kept its Buy rating on Amprius Technologies (AMPX) on March 06, 2026 and raised the price target to $21. The firm described the company as in the “still very early days” of commercialization, which underpins the maintained Buy stance. This move is notable because it combines affirmation of growth prospects with a higher target, indicating rising analyst conviction.
What the maintained Buy and $21 price target mean for investors
A maintained Buy shows the analyst sees more upside than downside from current levels and expects execution to drive value. For investors this means patience may be required as the company scales production and revenue. The $21 price target sets a reference point for potential appreciation, but it is not a guarantee of timing or outcome.
How the AMPX analyst rating ties to recent results and guidance
Amprius reported Q4 2025 results and gave a 2026 revenue outlook of $125,000,000, which helped inform Craig-Hallum’s view. The analyst highlighted product adoption, including SiCore, and progress on NDAA-compliant supply. Those operational details are central to the maintained Buy because they underpin margin expansion and revenue growth assumptions.
Stock performance context and market metrics
Since the analyst note, AMPX moved -4.22% ($-0.72) on the session reported with this update. The company’s market cap stands at $2,132,105,913. Those figures show that while the analyst raised a price target and kept a Buy, the market can still react negatively in the short term to earnings details or trading dynamics.
Historical analyst coverage and what makes Craig-Hallum’s view relevant
Analyst coverage for Amprius has been selective, making Craig-Hallum’s voice influential among professional investors. Historically, coverage has focused on commercialization milestones and battery adoption trends. Craig-Hallum’s continued coverage and PT increase suggest the firm sees measurable progress versus prior quarters.
Risks investors should watch despite the AMPX analyst rating
Key risks include production scaling, supply chain constraints, and competitive moves in advanced battery technology. Execution risk could delay revenue milestones. Investors should monitor quarterly production metrics, customer adoption of SiCore, and updates on NDAA-compliant supply arrangements.
Final Thoughts
Craig-Hallum’s decision on March 06, 2026 to maintain a Buy rating for Amprius Technologies while raising the price target to $21 reinforces a bullish medium-term view tied to product adoption and revenue guidance. The AMPX analyst rating reflects confidence in the company’s path to larger-scale commercial revenue, especially given the 2026 revenue target of $125,000,000 and traction on NDAA-compliant supply. However, the market reacted with a -4.22% ($-0.72) move on the session tied to the update, which shows short-term volatility can persist. Meyka AI rates AMPX with a grade of B. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors. Use the maintained Buy and the $21 price target as one data point in your research, and watch upcoming operational reports for confirmation of the analyst thesis.
FAQs
What changed in the AMPX analyst rating on March 06, 2026?
Craig-Hallum maintained its Buy rating on Amprius (AMPX) while raising the price target to $21 on March 06, 2026, citing early commercial progress and growth potential.
How should investors interpret the maintained Buy for AMPX?
A maintained Buy means the analyst still foresees net upside versus risk, based on product adoption and revenue guidance. Investors should weigh the rating alongside execution milestones and short-term volatility.
Does the new price target change the risk profile for AMPX?
Raising the price target to $21 signals increased confidence but does not eliminate execution risk. Key risks remain production scaling and supply chain constraints.
Where can I read the analyst note and related earnings context?
Craig-Hallum’s note raising the PT to $21 is covered by StreetInsider, and the company’s Q4 2025 earnings and 2026 guidance are summarized on Seeking Alpha for additional context.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)